AMP Timeline
The APD - timeline

Timeline of Antimicrobial Peptide Discovery

Year
Representative AMPs Selected by the APD3 Database
1922
discovered by Alexander Fleming (suggested by Robert Lehrer). This discovery declares the birth of modern innate immunity (Richard Gallo). Note that in 1928, Fleming discovered penicillin, the first dipeptide antibiotic in human history.

1928
(only antibacterial activity was noticed in 1928 and the structure determination was a long journey)

1939
(bacteria), the first linear channel-forming peptide antibiotic used clinically

1942
Purothionins found from plants

1944
the first circular peptide antibiotic discovered from bacteria and used clinically to treat wounds (earlier literature in Russian)

1947
(bacteria), the last resort to treat resistant Gram-negative superbugs

1967
established as an AMP

1970


1973
Plant Kalata B1 (identified as a uterotonic drug)

1974


1979


1981


1985
; Microcin

1986
, Pardaxins 1-3 (identified),

1987


1988
Horseshoe crab , ,

1989
; horseshoe crab Polyphemusin, HNP4, Patellamide

1990
bacterial Duramycin,

1991
pig cathelicidin ,

1992
, frog Brevinin, bovine Indolicidin, (known smallest lantibiotic),

1993
, Bovine beta defensins, pig Protegrin, amphibian Caerin, plant antifungal peptides

1994
Amphibian Dermaseptin, Esculentin, Avian defensin, Protozoan amoebapore

1995
, hBD-1

1996
LL-37; , Thanatin, Buforin, Uperin, Mytilin, Pardaxin 4 (antibacterial activity detected)

1997
Clavanin, Styelin, hBD-2

1998
Lactoferrin, Ranaturin, Maculatin, Lycotoxin, Granulysin

1999
Circulin, , (a prototype plant cyclotide is established as an AMP)

2000
thrombocidin (the first antimicrobial chemokine), Aurein, rCRAMP, Palustrin, the first gly-rich Shepherins from plants

2001
hBD-3, hBD-4, Ponericin, ,

2002
; Maximin, Hepcidin, Cupiennin, Retrocyclin, Halocidin

2003
is approved by FDA as a new antibiotic. human angiogenins, human chemokine (e.g. CCL20), Alo-1, Circularin A, PhD1, Halocin C8 (archaeocins)

2004
Arenicin, , Ascaphin, Caenacin (Gly-rich)

2005
human psoriasin (S100A7), , Phylloseptin

2006
human RNase 8; Latarcin, Cycloviolacin, Lividin

2007
Dybowskin, Pleurain, Hyposin, Odorranain, AvBD,

2008
human RNase 3; BTD, Vibi

2009
cn-AMP, Kassinatuerin, , Lichennicidin, Myxinidin

2010
Caenopore-5, , , Centrocin, Beta-amyloid peptide, Thuricin CD

2011
LCI (no disulfide bond beta sheet), Glycocin F (class 4 bacteriocin is found), frog cathelicidin-AL, PAM1

2012
(7 thioether rings), uncyclotide ChaC7 (i.e open chained), Microcin S (103AA), Slerocin, fungal Eurocin, fungal Micasin,

2013
, Protozoan Acanthaporin with a unique fold

2014
; fungal defensin ; human RNase 6; Human alpha defensin HD-6 is established as an AMP; BacFL31; Baceridin; Lassomycin; sonorensin; EcAMP3; Hispidalin; Crotalicidin. Highlighted in Antimicrobial Peptides in 2014

2015
; BnPRP1 (Pro-rich from plants); Ep-AMP1; from a commensal bacterium

2016
, a unique sequence from protist; , a circular peptide via a non-peptide bond; MjPen-II (a multiple domain AMP); , another form of human cathelicidin

2017
, specific inhibition of influenza A virus H1N1; , a defensin with a unique fold by forming 5 intermolecular disulfide bonds.
2018
, a ribosome-binding Pro-rich peptide from sea mammals; Rattusin, a rat alpha-defensin with a unique fold by forming five intermolecular disulfide bonds
2019
, an innate immune peptide inolved in the process of insect sleep; induced by vitamin A;
2020
;
2021

2022

2023


Acknowledgements: We thank Michael Zasloff and Robert Lehrer for suggestions.





First Established: March 2012 | updated Jan 2024 | Copyright 2003-2024 Dept of Pathology, Microbiology and Immunology, UNMC All Rights Reserved